NYSE:HUM - Humana Stock Price, Forecast & News

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Humana announced a quarterly dividend on Thursday, October 24th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.55 per share on Friday, January 31st. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date of this dividend is Monday, December 30th. View Humana's Dividend History.

Humana Inc (NYSE:HUM) issued its quarterly earnings data on Wednesday, February, 5th. The insurance provider reported $2.28 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $2.20 by $0.08. The insurance provider earned $16.30 billion during the quarter, compared to analyst estimates of $16.15 billion. Humana had a return on equity of 20.89% and a net margin of 4.17%. The business's quarterly revenue was up 15.0% on a year-over-year basis. During the same period last year, the firm posted $2.65 EPS. View Humana's Earnings History.

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for Humana.

Humana updated its FY20 earnings guidance on Wednesday, February, 5th. The company provided EPS guidance of $18.25-18.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $18.63.

16 Wall Street analysts have issued 1-year price objectives for Humana's stock. Their forecasts range from $290.00 to $460.00. On average, they expect Humana's stock price to reach $384.88 in the next twelve months. This suggests a possible upside of 2.9% from the stock's current price. View Analyst Price Targets for Humana.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.

Headlines about HUM stock have been trending neutral this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Humana earned a coverage optimism score of 0.3 on InfoTrie's scale. They also assigned media coverage about the insurance provider a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the company's share price in the next few days. View News Stories for Humana.

Humana saw a decrease in short interest in January. As of January 31st, there was short interest totalling 1,930,000 shares, a decrease of 11.5% from the January 15th total of 2,180,000 shares. Based on an average daily volume of 934,800 shares, the short-interest ratio is currently 2.1 days. Currently, 1.5% of the shares of the stock are short sold. View Humana's Current Options Chain.

Some companies that are related to Humana include UnitedHealth Group (UNH), Cigna (CI), Anthem (ANTM), Centene (CNC), WellCare Health Plans (WCG), Molina Healthcare (MOH), Magellan Health (MGLN) and Triple-S Management (GTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Mastercard (MA), Visa (V), Boeing (BA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Cigna (CI).

Humana's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (4.71%), State Street Corp (4.36%), Renaissance Technologies LLC (2.23%), Newport Trust Co (1.19%), Janus Henderson Group PLC (1.17%) and Boston Partners (1.16%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James J /Ky Obrien, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

HUM stock was sold by a variety of institutional investors in the last quarter, including GQG Partners LLC, Ceredex Value Advisors LLC, Maverick Capital Ltd., Janus Henderson Group PLC, Marshall Wace North America L.P., Marshall Wace LLP, FMR LLC and Point72 Asset Management L.P.. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Christopher H Hunter, Elizabeth D Bierbower, James J /Ky Obrien, Roy A Beveridge, Timothy Alan Wheatley and Timothy S Huval. View Insider Buying and Selling for Humana.

HUM stock was acquired by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Man Group plc, Boston Partners, First Trust Advisors LP, Panagora Asset Management Inc., Schroder Investment Management Group, Credit Suisse AG and PGGM Investments. View Insider Buying and Selling for Humana.

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of HUM stock can currently be purchased for approximately $374.00.

Humana has a market capitalization of $49.53 billion and generates $64.89 billion in revenue each year. The insurance provider earns $2.71 billion in net income (profit) each year or $17.87 on an earnings per share basis. Humana employs 41,600 workers across the globe.View Additional Information About Humana.

The official website for Humana is http://www.humana.com/.

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]